Seven Best Intraday Stocks to Buy Today with Strong Growth Potential

In today’s dynamic market, identifying stocks to buy that offer both stability and growth potential requires careful analysis. The following seven stocks represent best intraday trading opportunities, each with analysts projecting significant upside from current valuations. What makes these stocks to buy today particularly attractive is their relatively low volatility—with beta values ranging from 0.47 to 1.31—combined with strong fundamental drivers and analyst consensus ratings of “buy” to “strong buy.”

These selections offer something for every investor looking for stocks to buy today: from established companies to emerging growth stories. Each presents a unique investment thesis grounded in solid business fundamentals rather than speculative hype.

Tech & Healthcare Leaders: Exact Sciences (EXAS) and Alibaba (BABA)

Exact Sciences (NASDAQ: EXAS) built its reputation on Cologuard, a non-invasive colorectal screening test that has achieved significant commercial success. When evaluating best intraday stocks to buy today, EXAS stands out with its market-leading position and strong growth trajectory. The company reported approximately 17% revenue growth expectations with screening test revenue projected to expand by 31% annually. Trading near $61, analyst targets range from $73 to $130, suggesting over 100% upside potential. With a beta of 1.27, the stock shows slightly elevated volatility but remains suitable for investors seeking stocks to buy today with meaningful growth catalysts.

Alibaba (NYSE: BABA) represents a contrarian play among the best intraday stocks to buy today, particularly given its dominant position in Chinese cloud computing. Despite facing competitive pressure from emerging players like PDD Holdings, Alibaba maintains structural advantages in cloud infrastructure. The stock trades below analyst low targets, with some forecasts reaching $220—more than doubling current levels. Notably, prominent investor Michael Burry’s Scion Asset Management has made BABA its largest holding, signaling institutional confidence. The company’s beta of just 0.47 reflects exceptional stability, making it a compelling choice for risk-conscious investors scanning for stocks to buy today.

Resource & Industrial Plays: Sociedad Quimica y Minera (SQM) and Darling Ingredients (DAR)

Sociedad Quimica y Minera (NYSE: SQM) exemplifies the kind of contrarian opportunity that often emerges when sector sentiment shifts. As a lithium mining leader, SQM achieved record extraction volumes despite lithium price weakness that temporarily pressured revenues. The fundamental thesis remains intact: electric vehicle adoption is established and irreversible, ensuring eventual lithium demand recovery. Trading at $43 with targets as high as $90.50, the stock offers attractive risk-reward for patient investors. Its beta of 1.05 indicates market-average volatility, reinforcing why analysts continue highlighting SQM among stocks to buy today despite near-term headwinds.

Darling Ingredients (NYSE: DAR) operates a sustainable business model, repurposing approximately 15% of global meat processing byproducts into renewable diesel and specialty ingredients through over 260 facilities worldwide. The company anticipated its sixth consecutive year of record earnings, demonstrating consistent execution. At $42, with target prices reaching $120, DAR offers substantial upside. The company’s beta of 1.31 sits at the higher end of this stocks-to-buy-today list but remains well-managed. Recent strong quarterly guidance underscores why institutional analysts maintain constructive ratings on this holding.

Pharma & Specialty Sectors: Evotec SE (EVO), Triple Flag Precious Metals (TFPM), and MGP Ingredients (MGPI)

Evotec SE (NASDAQ: EVO) partners with leading pharmaceutical firms globally, focusing on AI-accelerated drug target discovery—a transformative application in biotech. Trading near $7, the stock commands expectations of price doubling among market participants. The company demonstrated 14% revenue growth with €580.1 million in sales and recently secured a $25 million payment from Bristol-Myers Squibb for a neuroscience collaboration. Its recent partnership with French firm Owkin to deploy AI for discovery applications highlights emerging growth vectors. With a beta of 1.09, EVO represents one of the best intraday stocks to buy today for those seeking biotech exposure with proven partnerships.

Triple Flag Precious Metals (NYSE: TFPM), a gold streaming and royalty company, carries negative beta—meaning it often appreciates when markets decline. This characteristic makes TFPM valuable for portfolio diversification, particularly among investors buying stocks to buy today as a hedge against equity market volatility. Gold historically rises during periods of economic uncertainty as investors seek assets disconnected from central bank policy. Strong analyst target prices support the fundamental investment case for this contrarian positioning.

MGP Ingredients (NASDAQ: MGPI) produces food-grade and industrial-grade alcohol products, operating as a diversified spirits producer and supplier. Established in 1941, the company boasts proven stability with a beta below 0.8, making it ideal for conservative investors identifying stocks to buy today. Recently, Wedbush elevated MGPI to its “best ideas list” with an outperform rating, citing strong return potential. The company’s ownership of multiple commercially available spirit brands, combined with its legacy customer relationships in the alcohol industry, provides durable competitive advantages.

Building Your Optimal Portfolio: How to Choose Your Stocks to Buy Today

When evaluating these seven stocks to buy today, consider your investment timeline, risk tolerance, and portfolio objectives. The collection spans technology, healthcare, commodities, and consumer sectors—enabling meaningful diversification. Investors with contrarian outlooks may prioritize Alibaba, SQM, or TFPM, where consensus sentiment lags fundamental strength. Growth-focused investors might concentrate on Exact Sciences, Evotec, and Darling Ingredients, where business acceleration is underway.

Beta values serve as a useful guide: picks below 1.0 (Alibaba at 0.47, MGP Ingredients below 0.8) suit conservative portfolios, while those between 1.0-1.4 appeal to moderate-risk investors. Critically, analyst consensus—maintained at “buy” or “strong buy” across this list—reflects professional conviction that each stock to buy today offers meaningful appreciation potential from current levels.

The fundamental principle uniting these stocks to buy today is simple: each trades below analyst median targets by a meaningful margin while exhibiting business strength. For investors committed to disciplined, research-backed stock selection, this portfolio offers a balanced foundation for long-term wealth building.